Pelvic Inflammatory Disease – Schnittstellen zwischen Hausarztpraxis und gynäkologischer Spezialabklärung

Die «Pelvic Inflammatory Disease» (PID) beschreibt eine aufsteigende Entzündung des oberen weiblichen Genitaltraktes, beginnend bei einer Zervizitis über eine Endometritis zur Adnexitis. Sie ist ein häufiges und in den letzten Jahren wieder zunehmendes klinisches Bild, das sowohl in der gynäkologischen wie auch hausärztlichen Praxis vorkommt. Die Symptome sind unspezifisch, diskret ausgebildet oder ganz fehlend. Eine schnelle Diagnosestellung mit unverzüglicher Therapieeinleitung sowie eine gute interdisziplinäre Zusammenarbeit können das Langzeitrisiko der chronischen Unterbauchschmerzen, Sterilität und/oder Extrauteringravidität mindern. Screeningprogramme auf Chlamydien und Gonokokken, die die häufigsten Erreger der PID darstellen, sind bisher in der Schweiz nicht implementiert

Sorbent Materials for Carbon Dioxide Separation

patent submitter:ZHAW - Zürcher Hochschule für Angewandte WissenschaftenThe present invention relates to a sorbent material for separation, preferably isothermal separation, of carbon dioxide from a gas mixture. Said sorbent material comprises either a cross-linked and substituted branched polyethylenimine containing a substituent –CH2–R substituting an amine nitrogen and a linker moiety –L– connecting amine nitrogens, or a solid support impregnated with or coated with a substituted branched polyethylenimine containing a substituent –CH2–R substituting an amine nitrogen. The present invention further provides processes of manufacturing the sorbent materials and methods of separation of carbon dioxide from a gas mixture using said sorbent materials

Permanent Tunneled Drainage of Ascites in Palliative Patients: Timing Needs Evaluation

Background: Treatment of refractory ascites remains challenging. We evaluated the safety and efficacy of permanent tunneled peritoneal catheters (PTPC) in this condition. Methods: We retrospectively analyzed consecutive patients in palliative situations in a tertiary referral center. Safety parameters, symptom relief, and survival were assessed. Results: Seventy patients were included from February 2012 to January 2021. Ninety percent had ascites due to malignancy, 10% due to end-stage liver disease. The technical procedure was successful in all cases; no deaths occurred. Procedure-related infections were rare and only observed in patients without peri-interventional antibiotics. Most patients experienced symptom relief (76%) and were satisfied with the device (83%). Survival after PTPC was relatively short (median 19 days). Discussion: PTPC is a safe option for refractory ascites in palliative settings with symptom relief in the majority of patients and should be considered early after onset of ascites. Periprocedural antibiotic prophylaxis may be considered to avoid procedure-related infections